Direct Pulp Capping Versus Pulpotomy for Primary Molars
Launched by KING ABDULLAH UNIVERSITY HOSPITAL · May 7, 2025
Trial Information
Current as of August 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Aim: The aim of this study is to evaluate the clinical and radiographic outcomes of direct pulp capping (DPC) when compared to pulpotomy in primary molars with carious pulp exposure using a calcium silicate-based material: neo mineral trioxide aggregate (Neo MTA).
Methods: The study will be a split mouth randomized clinical trial including children between 4-9 years old. Patients will be allocated into two treatment groups; one group will start with DPC first followed by pulpotomy on the second visit, and vice versa for the second group. The time interval between both visits will be 1-2 we...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy patients.
- • Age 4-10 years.
- • Primary molar with deep caries present bilaterally.
- • Teeth should be restorable.
- • Clinically normal asymptomatic tooth or symptoms of reversible pulpitis (No history of pain or provoked pain subsides upon removal of the stimulus).
- • Radiographically: caries in the inner half of the dentin approaching the pulp.
- Exclusion Criteria:
- • History of spontaneous pain.
- • Soft and hard tissue pathology.
- • Mobility or exfoliating tooth.
- • No pulp exposure after caries excavation.
- • Inability to achieve hemostasis after 6 minutes.
- • Radiographically: Root resorption exceeding 1/3 of the root, apical pathology.
About King Abdullah University Hospital
King Abdullah University Hospital (KAUH) is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. Located in Jordan, KAUH is committed to enhancing medical knowledge and improving treatment outcomes by conducting rigorous clinical trials across various therapeutic areas. The hospital is equipped with state-of-the-art facilities and a multidisciplinary team of healthcare professionals, ensuring the highest standards of research integrity and participant safety. Through its collaborative approach and focus on evidence-based medicine, KAUH aims to contribute significantly to the global medical community and the well-being of patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Irbid, , Jordan
Patients applied
Trial Officials
OLA Al-Batayneh
Principal Investigator
Jordan University of Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported